ADVERTISEMENT

Conference Report

PANTHER: Should Clopidogrel Become the 'New Aspirin' in CAD?

01 September 2022

A P2Y12 inhibitor, such as clopidogrel or ticagrelor, might be a better choice than aspirin for antiplatelet monotherapy in patients with coronary artery disease, results of a new meta-analysis suggest.

The PANTHER meta-analysis showed that P2Y12 inhibitor treatment lowered the risk for subsequent ischemic events, particularly myocardial infarction (MI), compared...

          

November Challenge

Ends in 10h
left
right

Topic Challenges

left
right